Ono Pharmaceutical Co. Ltd (ON4) - Cash Flow Conversion Efficiency

Latest as of March 2024: 0.062x

Based on the latest financial reports, Ono Pharmaceutical Co. Ltd (ON4) has a cash flow conversion efficiency ratio of 0.062x as of March 2024. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€49.16 Billion) by net assets (€798.61 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Ono Pharmaceutical Co. Ltd - Cash Flow Conversion Efficiency Trend (2016–2025)

This chart illustrates how Ono Pharmaceutical Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.

Ono Pharmaceutical Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Ono Pharmaceutical Co. Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Guangzhou Friendship Group Co Ltd SHE:000987	0.029x
Samsung Engineering KO:028050	-0.212x
Pharmaron Beijing Co Ltd SHE:300759	0.068x
Shin Kong Financial Holding Co Ltd TW:2888	-0.184x
Chengtun Mining Group Co Ltd SHG:600711	0.070x
SUZHOU KEMATEK INC SHE:301611	0.024x
MYTILINEOS SA NAM.EO 097 F:MYH	N/A
Chewy Inc NYSE:CHWY	0.443x

Annual Cash Flow Conversion Efficiency for Ono Pharmaceutical Co. Ltd (2016–2025)

The table below shows the annual cash flow conversion efficiency of Ono Pharmaceutical Co. Ltd from 2016 to 2025.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-03-31	€788.20 Billion	€82.46 Billion	0.105x	-24.50%
2024-03-31	€798.61 Billion	€110.66 Billion	0.139x	-35.08%
2023-03-31	€747.81 Billion	€159.61 Billion	0.213x	+128.41%
2022-03-31	€661.67 Billion	€61.83 Billion	0.093x	-19.01%
2021-03-31	€641.16 Billion	€73.98 Billion	0.115x	-11.62%
2020-03-31	€568.02 Billion	€74.16 Billion	0.131x	+10.02%
2019-03-31	€562.74 Billion	€66.77 Billion	0.119x	+299.59%
2018-03-31	€529.62 Billion	€15.73 Billion	0.030x	-79.09%
2017-03-31	€524.21 Billion	€74.45 Billion	0.142x	+426.70%
2016-03-31	€476.25 Billion	€12.84 Billion	0.027x	--

About Ono Pharmaceutical Co. Ltd

MU:ON4 Germany Drug Manufacturers - General

Market Cap

$7.05 Billion

€6.03 Billion EUR

Market Cap Rank

#2831 Global

#465 in Germany

Share Price

€12.84

Change (1 day)

-3.24%

52-Week Range

€8.95 - €14.60

All Time High

€714354.46